Article
Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) - 1 Apr 2007
Campa Daniele, Zienolddiny Shanbeh, Lind Helge, Ryberg David, Skaug Vidar, Canzian Federico, Haugen Aage
Abstract excerpt
BACKGROUND: The dopaminergic pathway may be of interest in assessing risk of non-small cell lung cancer (NSCLC). Dopamine receptors are expressed in alveolar epithelial cells and human lung tumours, and dopamine inhibits both cell proliferation in vitro and growth of lung tumour xenografts in nude mice. Moreover, dopamine selectively inhibits the vascular permeability and angiogenic activity of vascular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
